Introduction
Osteopetrosis, also known as marble bone disease, is a metabolic bone disorder that is characterized by a general increase of bone density resulting from a defect in osteoclast presence or function. Several genetically inherited forms of the disease have been described in humans. There are four spontaneous osteopetrotic mutations in mice that have been reported: op/op (osteopetrosis), mi/mi (microphtalmia), gl/gl (grey-lethal), and oc/oc (osteosclerosis). The osteoclast deficiency in op/op mice is due to a mutation in the coding region of the macrophage colony-stimu-lating factor gene (M-CSF1), 22 and a defect in a gene coding for a helix-loop-helix transcription factor is responsible for the microphtalmia phenotype. 13 Currently, the genes associated with oc or gl mutations have not been identified.
Osteosclerosis (oc) is a mouse osteopetrotic mutation inherited as an autosomal lethal recessive trait that arose spontaneously in 1966 at the Jackson Laboratory in the C57BL/6J-bf strain, 5 and has been backcrossed over 20 times to the hybrid C57BL/6Jle ϫ C3HeB/FeJLe-a/a F 1 , in order to increase the survival time of the affected oc/oc animals. The oc/oc homozygote mice usually die around 3 weeks of age, and the mutation has been maintained in oc/ϩ heterozygotes, which do not display any particular phenotype. Affected animals (oc/oc) exhibit the characteristic radiologic and histologic features of osteopetrosis, including a generalized increase in skeletal density and absence of marrow cavities easily detected by X-ray radiography (Figure  1) .
Oc was originally mapped to mouse chromosome 19 (MMU19) with fairly loose precision by Lane. 14 In 1985, Marks et al. 17 gave a better characterization of the phenotype and anchored the mutation in the pericentromeric region of MMU19. However, in this initial genetic mapping effort, the closest phenotypic marker brachymorphic (bm) was located 30 cM telomeric of oc, and no close markers were shown to segregate with the osteopetrotic phenotype. We have undertaken a comparative mapping study of a syntenic area of the genome that has been conserved through evolution between human 11q13 and the pericentromeric region of mouse chromosome 19. 4,8,21 Many genes involved in inherited human pathologies and localized on 11q13 have an homologous gene present on proximal MMU19 region and vice versa. 20 This gene conservation between mice and humans has been very helpful in designing new probes to refine the physical map. Moreover, it has been a source of candidate genes for positional cloning in both species. In our attempt to identify candidate genes for oc, we were able to exclude the Fos-related antigen 1 gene (fra-1), based on its segregation pattern and an allelism test, 19 as well as a putative transporter gene (Roct1), 3 based on physical mapping results (data not shown).
The positional cloning approach we followed consisted of four phases: defining the smallest candidate region based on proximal and distal meiotic recombination events, constructing a high-density physical map, sequencing the region of interest, and performing genomic database comparisons. In this report, we present evidence showing a 1.6-kb genomic deletion in mouse osteosclerotic mutants (oc/oc) removing the translation start site in the gene homologous to the human OC 116-kDa osteoclastspecific vacuolar proton pump subunit.
Materials and Methods

Mice
Two pairs of (C57BL/6J ϫ C3HheB/FeJ) F1 oc/ϩ mice were initially obtained from the Jackson Laboratory (Bar Harbor, ME) and maintained in our central animal facility in accordance with the general guidelines edicted by the Direction des Services Vétérinaires. Heterozygotes animals (oc/ϩ) were identified 3 weeks after birth by DNA genotyping (tail clipping) with a polymorphic marker (D19Mit68) cosegrating with the mutation. Animals suspected to be homozygous at the oc locus (smaller size than littermate, circling behavior, absence of or delayed incisors eruption) were systematically submitted to radiographic analysis for final phenotyping. Mus spretus mice (SEG imbred strain) were obtained from the Unité de Génétique des Mammifères (Institut Pasteur, Paris).
Yeast Artificial Chromosome (YACs) and Bacterial Artificial Chromosome (BAC) Identification
We initially identified YACs from the candidate region by screening four different mouse libraries (Princeton Library, MIT/ Whitehead Institute Library, St Mary's Hospital Library, and Imperial Cancer Research Fund (ICRF) Library). The screenings were performed with the help of either the Princeton or Généthon screening facility. BACs were then identified with polymerase chain reaction (PCR)-based screening of pooled libraries (Research Genetics, Huntsville, AL) with various STS from the interval. STS were obtained, mainly from BAC end-sequencing, but also by taking advantage of the conservation between HSA11q13 and the pericentomeric region of MMU19.
BAC DNA Purification and BAC End-Sequencing
BAC DNAs were prepared using a Nucleobond PC kit from Macherey-Nagel (Hoerdt, France), according to the manufacturer's instructions. BAC end-sequencing reactions were performed with 5 g of template, using the Thermo Sequenase kit (Amersham, Les Ulis, France), and IRD700-or IRD800-labeled SP6 or T7 primers (MWG Biotech, Ebersberg, Germany). Sequencing reaction products were analyzed on a LI-COR Long ReadIR 4200 DNA sequencer (LI-COR Inc., Lincoln, NE)
Polymerase Chain Reaction
Polymerase chain reaction was performed using primers and annealing temperatures reported in Table 1 . The 25-L reaction volume contained 25 pmol of each primer, 3.13 pmol dNTPs, 1.5 mmol/L MgCl 2 , and 0.5 U of platinium Taq DNA polymerase (Life Technologies, Cergy Pontoise, France). After 2 min at 95°C, PCR was carried out for 35 cycles with the following steps: 94°C for 30 sec, annealing temperature for 30 sec, and 72°C for 30 sec. A final extension step at 72°C for 10 min concluded each reaction. Amplification was performed in a PTC-100 thermal cycler (MJ Research, Waltham, MA). Polymerase chain reaction products were analyzed by gel electrophoresis in 2% agarose gels.
MMUOC116 Positioning on the Physical Map
We used two primer pairs (D19 Car333 and D19Car319) for the positioning of MMUOC116, as illustrated in Figure 3 . Each pair corresponded, respectively, to the 5Ј and to the 3Ј end of the mouse gene, and upstream and downstream primers were as follows: D19Car333, 5Ј-TAGCTTGAAGCAGATTGTACG-3Ј and 5Ј-CTCAACTTCGGCTTAGGATC-3Ј; D19Car319, 5Ј-CAGCTCTTTATTCCTGTCCC-3Ј and 5Ј-CTTCATGCACCA-AGCAATCC-3Ј.
FISH
BAC DNA was labeled using nick-translation with biotin-14-dATP (Life Technologies). The labeled probe (1 g/slide) was coprecipitated with 30 g of mouse Cot-1 DNA (Life Technologies), denatured for 5 min at 70°C in hybridization mixture (50% formamide, 2ϫ SSC, 10% Dextran sulfate), and reannealed for 30 -60 min at 37°C. The probe was then hybridized on denatured pretreated metaphase chromosomes from mouse SV22-CD cell line 2 overnight in a moist chamber at 37°C. The following steps were performed as described previously. 8 Figure 1 . Radiographic images of a 14-day-old normal mouse (wt) and its osteosclerotic littermate (oc/oc). A general increase of bone density and disappearance of bone marrow space can be observed in the mutant. 
Table 1. Primers for PCR amplification of physical and genetic mapping markers
BAC Sequencing and Clone Assembly
BAC DNA was prepared according to a standard alkaline lysis protocol, and purified twice on a CsCl gradient. BAC DNA (20 g) was mechanically disrupted using a hydroshear device (Gene Machines, San Carlos, CA), generating genomic DNA fragments an average of 3 kb in size. BAC DNA fragments were repaired with T4 DNA polymerase, and ligated to BstXI adaptors (Invitrogen, Groningen, The Netherlands). DNA adaptor-ligated fragments were purified by electrophoresis on a 0.7% agarose (FMC Bioproducts, Rockland, ME) preparative gel. After electrophoresis, fragments were excised from the gel, purified on Qiaquick columns (Qiagen, Courtaboef, France), and ligated to pcDNA2.1 vector (Invitrogen). Recombinant plasmids were transformed into Escherichia coli DH10B cells by electroporation (Electromax; Life Technologies). Ampicillin-resistant bacterial clones were picked with a Flexy robot (Proteigene, Saint-Marcel, France) and inoculated in 96-well arrays. Clones corresponding to 12 96-well dishes (8ϫ BAC length) were end-sequenced on a Licor 4200 system (Li-Cor Inc., Lincoln, NE). Sequence assembly was performed using the Phred-Phrap software. 7
Genomic DNA Amplification and Sequencing
Genomic DNA (50 -100 ng) (prepared from mouse tail) was used as a matrix for amplification with the following upstream and downstream primers: 5Ј-ATCCTAAGCCGAAGTTGAGC-3Ј and 5Ј-TCCGTTTCCTCCTGGATGC-3Ј. Polymerase chain reaction products were purified using the High Pure PCR product purification kit (Roche Diagnostics, Meylan, France). After sequencing with IRD700-labeled reverse primer (MWG Biotech, Ebersberg, Germany), the analysis was performed as described above.
Reverse Transcription (RT)-PCR
We extracted total RNA from kidney with Extract All reagent (Eurobio, Les Ulis, France), and cDNA was generated using Expand reverse transcriptase (Roche) and p(dT) 15 oligonucleotide (Roche) in a 40-L reaction volume under conditions recommended by the manufacturer. Polymerase chain reaction was performed with the following upstream and downstream primers: 5Ј-ATCCTAAGCCGAAGTTGAGC-3Ј and 5Ј-TC-CGTTTCCTCCTGGATGC-3Ј. Polymerase chain reaction products were purified using the High Pure PCR product purification kit, and subcloned into pGEMT-Easy vector (Promega) according to the manufacturer's protocol. Recombinant plasmids were transformed into JM109 competent bacteria. Plasmid DNAs were prepared using the Wizard Plus SV miniprep kit (Promega, Charbonnieres, France), digested with Not I (two sites flanking the cloning site of the vector), and analyzed by gel electrophoresis in 2% agarose gel. After sequencing of plasmid DNAs with IRD700-labeled SP6 and M13u (universal) primers (MWG), the analysis was performed as described above. The GenBank accession number is AF188702.
Results
Genetic Mapping of the oc Mutation
In the present study, we have been able to refine the genetic localization of the oc gene in the pericentromeric region of mouse chromosome 19 using an interspecific intercross of the type: (B6C3-a/a F1 oc/ϩ ϫ Mus spretus)F1oc/ϩ ϫ (B6C3-a/a F1 oc/ϩ ϫ Mus spretus)F1oc/ϩ. Close to 400 F2 progeny were generated, and using eight microsatellite markers (D19Mit22, D19Mit31, D19Mit32, D19Mit42, D19Mit51, D19Mit68, D19Mit93, and D19Mit109), polymorphic between C57BL/6, C3H, and Mus spretus, 24 ϩ/? recombinants and 20 oc/oc recombinant animals were typed in more details (data not shown). Backcrossing the original mutant stock to B6C3-a/a F1 hybrids 17 in order to generate vigourous breeding stock introduced a C3H genetic background that was detected on MMU19 in heterozygotes oc/ϩ mice.
The analysis of these recombinants led to the definition of a minimal candidate region, with D19Mit32 representing the centromeric boundary and D19Mit93 the telomeric one. High-resolution genetic maps of mouse chromosomes have been generated in the European Collaborative Interspecific Mouse Backcross (EUCIB) project based on close to a thousand progeny produced by an interspecific backcross between C57BL/6 and Mus spretus. 6 In that project, the genetic distance between D19Mit32 and D19Mit93 ranges from 0.2 to 0.6 cM in the BSS and BSB crosses, respectively (http://www.informatics.jax.org/menus/ map_menu.shtml).
Finally, the systematic genotyping of over 200 oc/oc mice generated from the (B6C3-a/a F1 oc/ϩ) ϫ (B6C3-a/a F1 oc/ϩ) cross showed, invariably, B/B homozygous alleles for D19Mit68 segregating with the osteopetrotic phenotype (an example of the pedigree is shown in Figure 2) . Thus, a defined region bearing the C57BL/6 background in which the oc mutation appeared could be delimited by D19Mit32 and D19Mit93 and centered on D19Mit68.
Physical Mapping of the Candidate Region
Based on our genetic mapping results, a screening of YAC and BAC libraries was undertaken. From a first set of two YACs and three BACs, end probes were isolated and sequenced in order to derive new STS markers and build up a set of overlapping clones. A more in-depth study of the physical map of this region of the mouse genome will be published separately (manuscript in preparation). Five YACs and 12 BACs were finally retained for further characterization and were assembled in an STS contentbased contig shown in Figure 3A . To ascertain the localization of the YAC and BAC genomic clones at the same time as testing for chimerism, fluorescent in situ hybridization was systematically performed on mouse SV22-CD metaphase chromosomes; an example of such hybridization using BAC BO9 DNA as a probe is shown in Figure 3B . Aside from the three microsatellite MIT markers, D19Mit32, D19Mit68, and D19Mit93, three genes conserved between HSA11q13 and MMU19 were positioned on this contig (Gstp1, Smbp2, and Galn). Twenty-one new STSs were generated from sequence data obtained either from BAC/YAC clone insert-end or internal sequencing. Oligonucleotide sequences for these PCR assays as well as the annealing temperature and the size of the product generated from a C57BL/6 DNA template are presented in Table 1 . Five of these new STSs, present on BACs BP5 and/or BO9, display polymorphic PCR products between C57BL/6 and Mus spretus, which appeared to cosegregate with oc/oc animals like D19Mit68 (data not shown). We then generated a 1.1-Mb contig based on a set of overlapping BAC/YAC clones including both proximal and distal boundaries of the candidate region where oc had been located.
A Mouse Homologue of the Human 116-kDa V-ATPase Subunit Gene (MMUOC116) Is Mutated in oc/oc Mice
The physical and genetic mapping results guided our choice in the selection of two BACs of 120 kb (BP5) and 220 kb (BO9) for shotgun cloning and sequencing. Sequence comparison using BLAST-based software 1 between one of the contigs of BAC BO9 against several database (nr GenBank, dbEST, dbSTS, . . . ) identified five mouse ESTs (GenBank Accession Nos. AI663350, AI549720, AI180721, AI649394, AI607442) displaying sequence identity with one sequence contig of the BO9 clone. This set of ESTs showed a high degree of similarity to the cDNA sequence of a new human osteoclast-specific 116-kDa vacuolar proton pump subunit (OC-116KDa) (Genbank Accession No. U45285). 15 Based on the sequence of these five mouse ESTs, we designed oligonucleotide primers to perform RT-PCR experiments on mRNAs derived from kidneys of wt and oc/oc mice.
A set of primers chosen between exon 1 and exon 4 of OC116 revealed a major size difference between the RT-PCR products generated from wt or mutant mice (data not shown). While the corresponding bands of these RT-PCR products were gel purified, cloned, and sequenced, genomic sequencing was performed on DNA extracted from wt and oc/oc mice. A 1579-bp deletion starting in the middle of intron 1 and extending 62 bp into exon 3 was identified in the genomic DNA of oc/oc mice (Figure  4a,c) . This deletion removes the translation start site present at the beginning of exon 2. The sequence analysis of RT-PCR products derived from oc/oc mice showed either exon 1/exon 4 junctions (data not shown) or an alternative splice site in intron 1, 32 bp upstream from the 1579-bp genomic deletion ( Figure  4b ). Thus, while RT-PCR products between exon 1 and 4 are accurately spliced in kidneys of wt mice, a large genomic deletion removing exon 2 and most of exon 3 results in aberrant mRNA transcripts in mutant animals.
The predicted protein encoded by the mouse homologue of OC116 displays 84% identities and 91% similitudes at the amino acid level with its human homologue (Figure 5) . A recent study by Heinemann et al. 12 localized the OC116 gene at 11q13 by fluorescent in situ hybridization on human metaphase chromosomes and described the genomic organization of this gene. Based on these results and the sequence data of the five mouse ESTs described previously, we were able to predict the intron/ exon structure of MMUOC116. Similarly to what was found by Heinemann et al., we identified 20 exons ranging from 79 bp (exons 1 and 3) up to 221 bp (exon 4). The translation start site is also present in exon 2, and the UAG stop codon is in exon 20. Thus, based on the MMUOC116 gene location and the high similarity of amino acid sequence with human OC116-predicted protein, it is very likely that the gene we isolated, as being mutated in oc/oc mice, is the mouse homologue of the human OC116 gene.
Discussion
We have isolated the mouse homologue of a new human osteoclast-specific vacuolar proton pump subunit gene that appears to be deleted over 1.6 kb at its 5Ј end in osteosclerosis (oc/oc) mutants. This result was achieved by a positional cloning strategy starting from the segregation of the oc mutation in an interspecific genetic cross to define proximal and distal recombination boundaries, followed by physical mapping over several hundreds of kilobases, and finishing by the sequence of a 200-kb genomic area.
The human OC116 gene was isolated by Li et al. and reported as putative novel human osteoclast-specific vacuolar proton pump subunit. 15 We hypothesize that the 1.6-kb deletion present in oc/oc mice inactivates the normal expression of the MMUOC116 gene and, consequently, could be deleterious for the vacuolar proton pump localization and expression on apical membranes of osteoclast cells. Indeed, previous work by Nakamura et al. 18 demonstrated that although the vacuolar H ϩ -ATPase proton pump was still active in oc/oc mice and present throughout the cytoplasm, it was no longer found on the osteoclast apical membranes. One of the features of oc/oc mice osteoclasts is the absence of ruffled border formation, leading to a defect in bone resorption. Whether the mislocalization of the vacuolar proton pump to the outer membrane of osteoclasts is a cause or a consequence of this lack of ruffling remains to be discovered.
Recently, Heaney et al. described the mapping of human autosomal recessive osteopetrosis to a 14-cM interval on 11q13. 11 This rare form of human osteopetrosis is lethal within the first decade in the absence of bone marrow transplantation, 9, 10 and its phenotype presents many similarities with the osteosclerosis mutation. Based on the present work, it is very likely that mutations affecting OC116 gene expression could be responsible for this form of human osteopetrosis. Sequencing of the entire OC116 genomic sequence of such affected individuals is presently in progress in our laboratory.
Finally, Li et al have recently presented an abstract at the 21st American Society for Bone and Mineral Research Meeting, showing that knockout Ϫ/Ϫ mice for the OC116 gene were growth retarded, developed severe osteopetrosis with deficiencies in bone remodeling and tooth eruption, and died at about 4 weeks of age. 16 All these phenotypic features are highly similar to what has been described for oc/oc mice, and strongly suggest that the genomic DNA deletion we observed in the MMUOC116 gene is sufficient to account for this phenotype. 
